Throughout the last three months, 5 analysts have evaluated Dentsply Sirona XRAY, offering a diverse set of opinions from bullish to bearish. The following table encapsulates their recent ratings ...
In the latest quarter, 6 analysts provided ratings for Dentsply Sirona (NASDAQ ... by 4.03% from the previous average price target of $33.00. Exploring Analyst Ratings: An In-Depth Overview ...
DENTSPLY SIRONA Inc. XRAY is scheduled to release third ... The Zacks Consensus Estimate for EPS implies an improvement of 33.3% from the year-ago figure. ACADIA Pharmaceuticals ACAD has an ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback